Curated GI articles February 25th, 2022: Cologuard crosses $1 billion in revenues

Curated GI articles February 25th, 2022: Cologuard crosses $1 billion in revenues

Curated GI articles February 25th, 2022:
Cologuard crosses $1 billion in revenues
Capital Digestive Care Announces Transaction with Gastroenterology, Ltd. of Virginia Beach (Globe Newswire)
The business deal adds two new locations in Southeastern Virginia, expanding Capital Digestive Care’s footprint across the Mid-Atlantic region.
Cologuard crosses $1 billion in revenues (Next Services)
Exact Sciences recently announced its Q4 2021 results. The article highlights 13 takeaways from the earnings call.
The rise of gastroenterology megagroups (Becker’s GI & Endoscopy)
Megagroup gastroenterologists can overlap as members of a management service organization or health system, but some are still independent.
Medscape Gastroenterologist Lifestyle, Happiness & Burnout Report 2022 (Medscape)
Medscape surveyed more than 13,000 physicians and the report explores physicians’ happiness with their personal life and professional work.
Curbs on Insurers, Private Equity Sought for Medicare Pay Plan (Bloomberg Law)
The suggested changes range from limiting the role of private equity and health insurers in the program to revamping how spending targets for care are set.
Big Pharma’s pricing power still strong, New York gastroenterologist says (Becker’s GI & Endoscopy)
Big Pharma, private equity and private payers are some of the forces Gabriel Ionescu, MD sees as decision-makers in the future of healthcare.
Should Adenoma Detection Rates be Made Public? (Gastro Broadcast)
Dr. Weinstein and Dr. Kefalas discuss the importance of advocacy and coming together as independent GI practices to promote important issues.
Medtronic receives FDA approval for InterStim X™ system, a personalized sacral nerve stimulation therapy for bladder and bowel control (PR Newswire)
Medtronic’s bladder and bowel control portfolio offers the most personalized options to fit patient lifestyles.
Clinical Trials in IBD Found To Lack Demographic Balance (GI & Endoscopy News)
Clinical trials of treatments for inflammatory bowel disease enroll a smaller proportion of Black and Hispanic patients than white or Asian patients.
Telehealth Adoption Highest Among Diabetes, GI Care Providers (mHealth Intelligence)
Physician telehealth use broken down into age ranges showed that more younger physicians used telehealth than their older counterparts.
AMSURG Sees Increase in Colorectal Cancer, Urges Americans to Receive Timely Screenings (Business Wire)
AMSURG, a division of Envision Healthcare has observed an increase in CRC diagnoses and encouraging Americans to receive timely, appropriate screenings
Federal court strikes down part of HHS surprise billing rule (STAT)
A federal court on Wednesday struck down the Biden administration’s interpretation of a controversial part of the federal law banning surprise medical bills.
Updated ACG GERD Guideline Addresses Increased Scrutiny of PPI Therapy (Web MD)
The ACG has issued updated recommendations and practical guidance on the evaluation and management of GERD, including pharmacologic, lifestyle, surgical, and endoscopic management.
AGA: Consider De-Prescribing PPIs in Patients With ‘Murky’ Indications (MedPage Today)
A new clinical practice update suggests either abrupt discontinuation or tapering when appropriate.
Medtronic to provide underserved communities with AI- assisted colonoscopy technology for colon cancer screening (Medtronic)
One of the goals is to improve the detection of polyps that can lead to colorectal cancer, which is the most common cancer among adults in the U.S.
Cost of a colonoscopy in 30 US cities (Becker’s GI & Endoscopy)
The article highlights the most expensive cities in the U.S. to have a colonoscopy screening, according to Healthcare Bluebook.
Gastric polyps: a 10-year analysis of 18,496 upper endoscopies (BMC Gastroenterology)
The aim of the study was to precise the frequency of different types of gastric polyps in the population, and to analyze their possible association with other factors.
Cells in Fecal Wash a More Powerful Biomarker Than Biopsy for IBD Inflammation (Medscape)
A fecal wash sample yields more information and may help inform diagnosis, disease monitoring, and treatment selection.

More Hot headlines in GI
Potential for FDA approval nears for emerging NASH therapies (Healio)

Colon Polyp Resection Training and Techniques (GI & Endoscopy News)

Lilly reveals promising data in ulcerative colitis as it prepares for regulator filings
(Health Industry Hub)

Arizona ASC offers all-female colonoscopy teams to boost screening rates
(Becker’s GI & Endoscopy)

Dr. Maria T. Abreu Chosen to Lead American Gastroenterological Association in 2024 (University of Miami Health System)

FDA grants orphan drug designation to natural killer cell therapy for GI cancers (Healio)

Healthcare Industry Still Lacks Inclusivity And Accessibility (Forbes)

Walgreens opening 200 primary care clinics in 2022 (Medical Economics)

‘Milestone policy’ on physician mental health one step away from becoming law (Healio)

Two Studies Shed Light on IBD Treatment After Anti-TNF Failure (Medscape)

Videos: Interviews with GI Leaders  (NextServices)

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.

Write a Comment